A Public Health Critical Race Praxis Informed Congestive Heart Failure Quality Improvement Initiative on Inpatient General Medicine.

congestive heart failure health disparities hospital medicine quality improvement social determinants of health

Journal

Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834

Informations de publication

Date de publication:
08 2023
Historique:
received: 05 08 2022
accepted: 07 02 2023
medline: 9 8 2023
pubmed: 1 3 2023
entrez: 28 2 2023
Statut: ppublish

Résumé

Prior evaluation at our hospital demonstrated that, compared to White patients, Black and Latinx patients with congestive heart failure (CHF) were less likely to be admitted to the cardiology service rather than the general medicine service (GMS). Patients admitted to GMS (compared to cardiology) had inferior rates of cardiology follow-up and 30-day readmission. To develop and test the feasibility and impacts of using quality improvement (QI) methods, in combination with the Public Health Critical Race Praxis (PHCRP) framework, to engage stakeholders in developing an intervention for ensuring guideline-concordant inpatient CHF care across all patient groups. We compared measures for all patients admitted with CHF to GMS between September 2019 and March 2020 (intervention group) to CHF patients admitted to GMS in the previous year (pre-intervention group) and those admitted to cardiology during the pre-intervention and intervention periods (cardiology group). Our primary measures were 30-day readmissions and 14- and 30-day post-discharge cardiology follow-up. There were 79 patients admitted with CHF to GMS during the intervention period, all of whom received the intervention. There were similar rates of Black and Latinx patients across the three groups. Compared to pre-intervention, intervention patients had a significantly lower 30-day readmission rate (18.9% vs. 24.8%; p=0.024), though the cardiology group also had a decrease in 30-day readmissions from the pre-intervention to intervention period. Compared to pre-intervention, intervention patients had significantly higher 14-day and 30-day post-discharge follow-up visits scheduled with cardiology (36.7% vs. 24.8%, p=0.005; 55.7% vs. 42.3%, p=0.0029), but no improvement in appointment attendance. This study provides a first test of applying the PHCRP framework within a stakeholder-engaged QI initiative for improving CHF care across races and ethnicities. Our study design cannot evaluate causation. However, the improvements in 30-day readmission, as well as in processes of care that may affect it, provide optimism that inclusion of a racism-conscious framework in QI initiatives is feasible and may enhance QI measures.

Sections du résumé

BACKGROUND
Prior evaluation at our hospital demonstrated that, compared to White patients, Black and Latinx patients with congestive heart failure (CHF) were less likely to be admitted to the cardiology service rather than the general medicine service (GMS). Patients admitted to GMS (compared to cardiology) had inferior rates of cardiology follow-up and 30-day readmission.
OBJECTIVE
To develop and test the feasibility and impacts of using quality improvement (QI) methods, in combination with the Public Health Critical Race Praxis (PHCRP) framework, to engage stakeholders in developing an intervention for ensuring guideline-concordant inpatient CHF care across all patient groups.
METHODS
We compared measures for all patients admitted with CHF to GMS between September 2019 and March 2020 (intervention group) to CHF patients admitted to GMS in the previous year (pre-intervention group) and those admitted to cardiology during the pre-intervention and intervention periods (cardiology group). Our primary measures were 30-day readmissions and 14- and 30-day post-discharge cardiology follow-up.
RESULTS
There were 79 patients admitted with CHF to GMS during the intervention period, all of whom received the intervention. There were similar rates of Black and Latinx patients across the three groups. Compared to pre-intervention, intervention patients had a significantly lower 30-day readmission rate (18.9% vs. 24.8%; p=0.024), though the cardiology group also had a decrease in 30-day readmissions from the pre-intervention to intervention period. Compared to pre-intervention, intervention patients had significantly higher 14-day and 30-day post-discharge follow-up visits scheduled with cardiology (36.7% vs. 24.8%, p=0.005; 55.7% vs. 42.3%, p=0.0029), but no improvement in appointment attendance.
CONCLUSION
This study provides a first test of applying the PHCRP framework within a stakeholder-engaged QI initiative for improving CHF care across races and ethnicities. Our study design cannot evaluate causation. However, the improvements in 30-day readmission, as well as in processes of care that may affect it, provide optimism that inclusion of a racism-conscious framework in QI initiatives is feasible and may enhance QI measures.

Identifiants

pubmed: 36849864
doi: 10.1007/s11606-023-08086-7
pii: 10.1007/s11606-023-08086-7
pmc: PMC9970115
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2236-2244

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Institute of Medicine (U.S.). Committee on Quality of Health Care in America. Crossing the quality chasm : a new health system for the 21st century. National Academy Press; 2001:xx, 337 p.
Dzau VJ, Mate K, O'Kane M. Equity and Quality-Improving Health Care Delivery Requires Both. JAMA. Feb 8 2022;327(6):519-520. https://doi.org/10.1001/jama.2022.0283
doi: 10.1001/jama.2022.0283 pubmed: 35060998
Green AR, Tan-McGrory A, Cervantes MC, Betancourt JR. Leveraging quality improvement to achieve equity in health care. Jt Comm J Qual Patient Saf. Oct 2010;36(10):435-42. https://doi.org/10.1016/s1553-7250(10)36065-x
doi: 10.1016/s1553-7250(10)36065-x pubmed: 21548504
Hirschhorn LR, Magge H, Kiflie A. Aiming beyond equality to reach equity: the promise and challenge of quality improvement. BMJ. Jul 20 2021;374:n939. https://doi.org/10.1136/bmj.n939
doi: 10.1136/bmj.n939 pubmed: 34285002 pmcid: 8290315
O'Kane M, Agrawal S, Binder L, et al. An Equity Agenda for the Field of Health Care Quality Improvement. NAM Perspect. 2021;2021 https://doi.org/10.31478/202109b
Bahrami H, Kronmal R, Bluemke DA, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. Oct 27 2008;168(19):2138-45. https://doi.org/10.1001/archinte.168.19.2138
doi: 10.1001/archinte.168.19.2138 pubmed: 18955644 pmcid: 3038918
Chang PP, Chambless LE, Shahar E, et al. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. Feb 1 2014;113(3):504-10. https://doi.org/10.1016/j.amjcard.2013.10.032
doi: 10.1016/j.amjcard.2013.10.032 pubmed: 24342763
Durstenfeld MS, Ogedegbe O, Katz SD, Park H, Blecker S. Racial and Ethnic Differences in Heart Failure Readmissions and Mortality in a Large Municipal Healthcare System. JACC Heart Fail. Nov 2016;4(11):885-893. https://doi.org/10.1016/j.jchf.2016.05.008
Glynn P, Lloyd-Jones DM, Feinstein MJ, Carnethon M, Khan SS. Disparities in Cardiovascular Mortality Related to Heart Failure in the United States. J Am Coll Cardiol. May 14 2019;73(18):2354-2355. https://doi.org/10.1016/j.jacc.2019.02.042
doi: 10.1016/j.jacc.2019.02.042 pubmed: 31072580
Lewis EF, Claggett B, Shah AM, et al. Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial. Circ Heart Fail. Mar 2018;11(3):e004457. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004457
doi: 10.1161/CIRCHEARTFAILURE.117.004457 pubmed: 29664406
Nayak A, Hicks AJ, Morris AA. Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients. Circ Heart Fail. Aug 2020;13(8):e007264. https://doi.org/10.1161/CIRCHEARTFAILURE.120.007264
doi: 10.1161/CIRCHEARTFAILURE.120.007264 pubmed: 32787445 pmcid: 7644144
Patel SA, Krasnow M, Long K, Shirey T, Dickert N, Morris AA. Excess 30-Day Heart Failure Readmissions and Mortality in Black Patients Increases With Neighborhood Deprivation. Circ Heart Fail. Dec 2020;13(12):e007947. https://doi.org/10.1161/CIRCHEARTFAILURE.120.007947
Ziaeian B, Kominski GF, Ong MK, Mays VM, Brook RH, Fonarow GC. National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity. Circ Cardiovasc Qual Outcomes. Jul 2017;10(7) https://doi.org/10.1161/CIRCOUTCOMES.116.003552
Eberly LA, Richterman A, Beckett AG, et al. Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center. Circ Heart Fail. Nov 2019;12(11):e006214. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006214
doi: 10.1161/CIRCHEARTFAILURE.119.006214 pubmed: 31658831 pmcid: 7183732
Jong P, Gong Y, Liu PP, Austin PC, Lee DS, Tu JV. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation. Jul 15 2003;108(2):184-91. https://doi.org/10.1161/01.CIR.0000080290.39027.48
doi: 10.1161/01.CIR.0000080290.39027.48 pubmed: 12821540
Salata BM, Sterling MR, Beecy AN, et al. Discharge Processes and 30-Day Readmission Rates of Patients Hospitalized for Heart Failure on General Medicine and Cardiology Services. Am J Cardiol. May 1 2018;121(9):1076-1080. https://doi.org/10.1016/j.amjcard.2018.01.027
doi: 10.1016/j.amjcard.2018.01.027 pubmed: 29548676 pmcid: 6557434
Selim AM, Mazurek JA, Iqbal M, Wang D, Negassa A, Zolty R. Mortality and readmission rates in patients hospitalized for acute decompensated heart failure: a comparison between cardiology and general-medicine service outcomes in an underserved population. Clin Cardiol. Mar 2015;38(3):131-8. https://doi.org/10.1002/clc.22372
doi: 10.1002/clc.22372 pubmed: 25694226 pmcid: 6711015
Uthamalingam S, Kandala J, Selvaraj V, et al. Outcomes of patients with acute decompensated heart failure managed by cardiologists versus noncardiologists. Am J Cardiol. Feb 15 2015;115(4):466-71. https://doi.org/10.1016/j.amjcard.2014.11.034
doi: 10.1016/j.amjcard.2014.11.034 pubmed: 25637324
Cleveland Manchanda EC, Marsh RH, Osuagwu C, et al. Heart Failure Admission Service Triage (H-FAST) Study: Racialized Differences in Perceived Patient Self-Advocacy as a Driver of Admission Inequities. Cureus. Feb 16 2021;13(2):e13381. https://doi.org/10.7759/cureus.13381
doi: 10.7759/cureus.13381 pubmed: 33628703 pmcid: 7891794
Morse M, Loscalzo J. Creating Real Change at Academic Medical Centers - How Social Movements Can Be Timely Catalysts. N Engl J Med. Jul 16 2020;383(3):199-201. https://doi.org/10.1056/NEJMp2002502
doi: 10.1056/NEJMp2002502 pubmed: 32521157
Ford CL, Airhihenbuwa CO. The public health critical race methodology: praxis for antiracism research. Soc Sci Med. Oct 2010;71(8):1390-8. https://doi.org/10.1016/j.socscimed.2010.07.030
doi: 10.1016/j.socscimed.2010.07.030 pubmed: 20822840
Ford CL, Airhihenbuwa CO. Critical Race Theory, race equity, and public health: toward antiracism praxis. Am J Public Health. Apr 1 2010;100 Suppl 1:S30-5. https://doi.org/10.2105/AJPH.2009.171058
doi: 10.2105/AJPH.2009.171058 pubmed: 20147679 pmcid: 2837428
Williams JN, Ford CL, Morse M, Feldman CH. Racial Disparities in Rheumatology Through the Lens of Critical Race Theory. Rheum Dis Clin North Am. Nov 2020;46(4):605-612. https://doi.org/10.1016/j.rdc.2020.07.001
doi: 10.1016/j.rdc.2020.07.001 pubmed: 32981638
Hempel S, Bolshakova M, Turner BJ, et al. Evidence-Based Quality Improvement: a Scoping Review of the Literature. J Gen Intern Med. Dec 2022;37(16):4257-4267. https://doi.org/10.1007/s11606-022-07602-5
doi: 10.1007/s11606-022-07602-5 pubmed: 36175760 pmcid: 9708973
Heidenreich PA, Fonarow GC, Breathett K, et al. 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes. Nov 2020;13(11):e000099. https://doi.org/10.1161/HCQ.0000000000000099
doi: 10.1161/HCQ.0000000000000099 pubmed: 33136435 pmcid: 8388013
Capanu M, Gonen M, Begg CB. An assessment of estimation methods for generalized linear mixed models with binary outcomes. Stat Med. Nov 20 2013;32(26):4550-66. https://doi.org/10.1002/sim.5866
doi: 10.1002/sim.5866 pubmed: 23839712
Feltner C, Jones CD, Cene CW, et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med. Jun 3 2014;160(11):774-84. https://doi.org/10.7326/M14-0083
doi: 10.7326/M14-0083 pubmed: 24862840
Nair R, Lak H, Hasan S, Gunasekaran D, Babar A, Gopalakrishna KV. Reducing All-cause 30-day Hospital Readmissions for Patients Presenting with Acute Heart Failure Exacerbations: A Quality Improvement Initiative. Cureus. Mar 25 2020;12(3):e7420. https://doi.org/10.7759/cureus.7420
doi: 10.7759/cureus.7420 pubmed: 32351805 pmcid: 7186095
Van Spall HGC, Lee SF, Xie F, et al. Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial. JAMA. Feb 26 2019;321(8):753-761. https://doi.org/10.1001/jama.2019.0710
doi: 10.1001/jama.2019.0710 pubmed: 30806695 pmcid: 6439867
Van Spall HGC, Rahman T, Mytton O, et al. Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis. Eur J Heart Fail. Nov 2017;19(11):1427-1443. https://doi.org/10.1002/ejhf.765
doi: 10.1002/ejhf.765 pubmed: 28233442
White-Williams C, Rossi LP, Bittner VA, et al. Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association. Circulation. Jun 2 2020;141(22):e841-e863. https://doi.org/10.1161/CIR.0000000000000767
doi: 10.1161/CIR.0000000000000767 pubmed: 32349541
Lee KK, Yang J, Hernandez AF, Steimle AE, Go AS. Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization. Med Care. Apr 2016;54(4):365-72. https://doi.org/10.1097/MLR.0000000000000492
doi: 10.1097/MLR.0000000000000492 pubmed: 26978568 pmcid: 4800825
Ducharme A, Doyon O, White M, Rouleau JL, Brophy JM. Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. CMAJ. Jul 5 2005;173(1):40-5. https://doi.org/10.1503/cmaj.1041137
doi: 10.1503/cmaj.1041137 pubmed: 15997043 pmcid: 1167811
Stromberg A, Martensson J, Fridlund B, Levin LA, Karlsson JE, Dahlstrom U. Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial. Eur Heart J. Jun 2003;24(11):1014-23. https://doi.org/10.1016/s0195-668x(03)00112-x
doi: 10.1016/s0195-668x(03)00112-x pubmed: 12788301
Kasper EK, Gerstenblith G, Hefter G, et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. Feb 6 2002;39(3):471-80. https://doi.org/10.1016/s0735-1097(01)01761-2
doi: 10.1016/s0735-1097(01)01761-2 pubmed: 11823086
Ledwidge M, Barry M, Cahill J, et al. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? Eur J Heart Fail. Jun 2003;5(3):381-9. https://doi.org/10.1016/s1388-9842(02)00235-0
doi: 10.1016/s1388-9842(02)00235-0 pubmed: 12798838
McDonald K, Ledwidge M, Cahill J, et al. Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care. J Card Fail. Jun 2002;8(3):142-8. https://doi.org/10.1054/jcaf.2002.124340
doi: 10.1054/jcaf.2002.124340 pubmed: 12140806
McDonald K, Ledwidge M, Cahill J, et al. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge. Eur J Heart Fail. Mar 2001;3(2):209-15. https://doi.org/10.1016/s1388-9842(00)00134-3
doi: 10.1016/s1388-9842(00)00134-3 pubmed: 11246059
Ekman I, Andersson B, Ehnfors M, Matejka G, Persson B, Fagerberg B. Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J. Aug 1998;19(8):1254-60. https://doi.org/10.1053/euhj.1998.1095
doi: 10.1053/euhj.1998.1095 pubmed: 9740348
Dev S, Fawcett J, Ahmad S, Wu WC, Schwenke D. Implementation of early follow-up care after heart failure hospitalization. Am J Manag Care. Feb 1 2021;27(2):e42-e47. https://doi.org/10.37765/ajmc.2021.88588
doi: 10.37765/ajmc.2021.88588 pubmed: 33577160
Chaiyachati KH, Hubbard RA, Yeager A, et al. Association of Rideshare-Based Transportation Services and Missed Primary Care Appointments: A Clinical Trial. JAMA Intern Med. Mar 1 2018;178(3):383-389. https://doi.org/10.1001/jamainternmed.2017.8336
doi: 10.1001/jamainternmed.2017.8336 pubmed: 29404572
Powers BW, Rinefort S, Jain SH. Nonemergency Medical Transportation: Delivering Care in the Era of Lyft and Uber. JAMA. Sep 6 2016;316(9):921-2. https://doi.org/10.1001/jama.2016.9970
doi: 10.1001/jama.2016.9970 pubmed: 27599325
Jack BW, Chetty VK, Anthony D, et al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. Feb 3 2009;150(3):178-87. https://doi.org/10.7326/0003-4819-150-3-200902030-00007
doi: 10.7326/0003-4819-150-3-200902030-00007 pubmed: 19189907 pmcid: 2738592
Breathett K, D'Amico R, Adesanya TMA, et al. Patient Perceptions on Facilitating Follow-Up After Heart Failure Hospitalization. Circ Heart Fail. Jun 2017;10(6).  https://doi.org/10.1161/CIRCHEARTFAILURE.117.004099
Ansell DA, James B, De Maio FG. A Call for Antiracist Action. N Engl J Med. Jul 7 2022;387(1):e1. https://doi.org/10.1056/NEJMp2201950
doi: 10.1056/NEJMp2201950 pubmed: 35172050

Auteurs

Chidinma Osuagwu (C)

Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.

Roaa M Khinkar (RM)

Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

Amy Zheng (A)

Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Matthew Wien (M)

Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA.

Jennifer Decopain (J)

School of Nursing, MGH Institute of Health Professions, Charlestown, MA, USA.

Sonali Desai (S)

Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, USA.
Department of Quality and Safety, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Erin McElrath (E)

Department of Medicine, Brigham and Woman's Hospital, Boston, MA, USA.

Emily Hinchey (E)

Department of Medicine, Brigham and Woman's Hospital, Boston, MA, USA.

Stephanie K Mueller (SK)

Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Jeffrey L Schnipper (JL)

Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Robert Boxer (R)

Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Evan Michael Shannon (EM)

Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, 1100 Glendon Ave, Suite 850, Room, Los Angeles, CA, 812, USA. emshannon@mednet.ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH